Goldman Sachs’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $18.8K | Buy |
|
|||||
|
2023
Q4 | $17.8K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $59.6K | Buy |
|
|||||
|
2022
Q4 | $70.1K | Sell |
|
|||||
|
2022
Q3 | $213K | Sell |
|
|||||
|
2022
Q2 | $978K | Buy |
|
|||||
|
2022
Q1 | $1.67M | Sell |
|
|||||
|
2021
Q4 | $2.7M | Buy |
|
|||||
|
2021
Q3 | $1.04M | Buy |
|
|||||
|
2021
Q2 | $677K | Buy |
|
|||||
|
2021
Q1 | $516K | Buy |
|
|||||
|
2020
Q4 | $381K | Sell |
|
|||||
|
2020
Q3 | $938K | Buy |
|
|||||
|
2020
Q2 | $242K | Sell |
|
|||||
|
2020
Q1 | $152K | Buy |
|
|||||
|
2019
Q4 | $137K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $643K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $101K | Sell |
|
|||||
|
2018
Q2 | $411K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $383K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $86K | Buy |
|
|||||
|
2015
Q4 | $56K | Sell |
|
|||||
|
2015
Q3 | $61K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $81K | Buy |
|